North America
Thermo Fisher’s Integrated CDMO-CRO Model Cuts Drug Development Time by Up to 34 Months, Finds Tufts CSDD Study
Thermo Fisher Scientific Inc., the world leader in serving science, announced the findings of new research by the Tufts Center for the Study of Drug ...
June 17, 2025 | News
Visterra Licenses Nona Biosciences’ HCAb Harbour Mice® Platform to Advance Autoimmune Biotherapeutics
Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), today announced a license agreeme...
June 13, 2025 | News
Cytiva’s $1.6B Expansion Across 3 Continents to Boost Bioprocessing Supply
Faster delivery and productivity gains available thanks to expanded manufacturing capacity in chromatography resins, filtration, single-use bags and ...
June 12, 2025 | News
Deep Apple Therapeutics and Novo Nordisk Join Forces to Develop Next-Gen Oral Therapies for Cardiometabolic Diseases
- Deep Apple Therapeutics Announces Collaboration with Novo Nordisk to Discover and Develop Oral Therapies for Cardiometabolic Diseases The partnership ai...
June 12, 2025 | News
Insilico Medicine and AWS Bring Nach01 Generative AI Model for Drug Discovery to Global Researchers via AWS Marketplace
Insilico Medicine, a clinical-stage biotechnology company driven by generative artificial intelligence (AI), announced the recent release of its Nach...
June 11, 2025 | News
Alamar Biosciences, Gates Ventures, and Alzheimer's Disease Data Initiative Launch Global Effort to Build Largest Plasma Proteome Atlas for Alzheimer’s
Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, the Alzheimer's Disease Data Initiative and Gates ...
June 11, 2025 | News
Eluminex Reports Positive Phase 1 Results for EB-105 in Diabetic Macular Edema Patients
EB-105 Targets VEGF-A, -B, PlGF, Ang-2, and IL-6R Improvements in Visual Acuity and Retinal Edema Observed at All Dose Levels No Safety Issues Observed...
June 10, 2025 | News
ASCO 2025 Showcases New Oncology Paradigms, From Breast Cancer Breakthroughs to AI-Led Precision Medicine
The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting wasn’t just another scientific gathering and it was a seismic event that redrew ...
June 06, 2025 | Report
Continuity Biosciences Acquires Focal Medical to Advance Site-Specific Chemotherapy for Pancreatic Cancer
Continuity Biosciences, LLC, a developer of advanced drug delivery technologies, announced the acquisition of Focal Medical, Inc., a North Carol...
June 05, 2025 | News
SCIEX Launches ZenoTOF 8600 System to Redefine Mass Spectrometry Quantitation Across Omics Research
SCIEX, a global leader in life science analytical technologies and operating company of Danaher Corporation (NYSE: DHR), launches the ZenoTOF 86...
June 04, 2025 | News
Protagonist Therapeutics and Takeda Report Positive Phase 3 Results for Rusfertide in PV, Meeting All Primary and Secondary Endpoints
Rusfertide plus current standard of care more than doubled clinical response rates across high- and low-risk PV groups, significantly reducing phleboto...
June 03, 2025 | News
Kexing Biopharm’s GB18 Receives IND Approval in China and U.S. for Cancer Cachexia Treatment
Kexing Biopharm (688136.SH) announced that the National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND) applica...
May 30, 2025 | News
Teddy Laboratory and LabConnect Forge Global Lab Alliance to Accelerate Drug Development
Teddy Laboratory, a subsidiary of Tigermed, officially signed a strategic cooperation agreement with LabConnect, LLC, a global leader in central labor...
May 30, 2025 | News
Celltrion’s YUFLYMA® Wins Expanded Interchangeability Status for All Humira® Dosage Forms in the U.S.
YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar[1] Cellt...
May 26, 2025 | News
Most Read
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
